NO952907D0 - Transdermalt terapeutisk system med galanthamin som virksom bestanddel - Google Patents
Transdermalt terapeutisk system med galanthamin som virksom bestanddelInfo
- Publication number
- NO952907D0 NO952907D0 NO952907A NO952907A NO952907D0 NO 952907 D0 NO952907 D0 NO 952907D0 NO 952907 A NO952907 A NO 952907A NO 952907 A NO952907 A NO 952907A NO 952907 D0 NO952907 D0 NO 952907D0
- Authority
- NO
- Norway
- Prior art keywords
- galanthamine
- pct
- transdermal therapeutic
- therapeutic system
- active ingredient
- Prior art date
Links
- ASUTZQLVASHGKV-JDFRZJQESA-N galanthamine Chemical compound O1C(=C23)C(OC)=CC=C2CN(C)CC[C@]23[C@@H]1C[C@@H](O)C=C2 ASUTZQLVASHGKV-JDFRZJQESA-N 0.000 title abstract 4
- HPOIPOPJGBKXIR-UHFFFAOYSA-N 3,6-dimethoxy-10-methyl-galantham-1-ene Natural products O1C(C(=CC=2)OC)=C3C=2CN(C)CCC23C1CC(OC)C=C2 HPOIPOPJGBKXIR-UHFFFAOYSA-N 0.000 title abstract 2
- LPCKPBWOSNVCEL-UHFFFAOYSA-N Chlidanthine Natural products O1C(C(=CC=2)O)=C3C=2CN(C)CCC23C1CC(OC)C=C2 LPCKPBWOSNVCEL-UHFFFAOYSA-N 0.000 title abstract 2
- 229960003980 galantamine Drugs 0.000 title abstract 2
- BGLNUNCBNALFOZ-WMLDXEAASA-N galanthamine Natural products COc1ccc2CCCC[C@@]34C=CCC[C@@H]3Oc1c24 BGLNUNCBNALFOZ-WMLDXEAASA-N 0.000 title abstract 2
- ASUTZQLVASHGKV-UHFFFAOYSA-N galanthamine hydrochloride Natural products O1C(=C23)C(OC)=CC=C2CN(C)CCC23C1CC(O)C=C2 ASUTZQLVASHGKV-UHFFFAOYSA-N 0.000 title abstract 2
- IYVSXSLYJLAZAT-NOLJZWGESA-N lycoramine Natural products CN1CC[C@@]23CC[C@H](O)C[C@@H]2Oc4cccc(C1)c34 IYVSXSLYJLAZAT-NOLJZWGESA-N 0.000 title abstract 2
- 230000001225 therapeutic effect Effects 0.000 title abstract 2
- 239000004480 active ingredient Substances 0.000 title 1
- 239000004820 Pressure-sensitive adhesive Substances 0.000 abstract 1
- 239000013543 active substance Substances 0.000 abstract 1
- USUHXXKCHSBMOS-XPSHAMGMSA-N galanthamine hydrochloride Chemical compound Cl.O1C(=C23)C(OC)=CC=C2CN(C)CC[C@]23[C@@H]1C[C@@H](O)C=C2 USUHXXKCHSBMOS-XPSHAMGMSA-N 0.000 abstract 1
- 239000000463 material Substances 0.000 abstract 1
- 239000004014 plasticizer Substances 0.000 abstract 1
- 229920000058 polyacrylate Polymers 0.000 abstract 1
- 150000003839 salts Chemical class 0.000 abstract 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/70—Web, sheet or filament bases ; Films; Fibres of the matrix type containing drug
- A61K9/7023—Transdermal patches and similar drug-containing composite devices, e.g. cataplasms
- A61K9/703—Transdermal patches and similar drug-containing composite devices, e.g. cataplasms characterised by shape or structure; Details concerning release liner or backing; Refillable patches; User-activated patches
- A61K9/7038—Transdermal patches of the drug-in-adhesive type, i.e. comprising drug in the skin-adhesive layer
- A61K9/7046—Transdermal patches of the drug-in-adhesive type, i.e. comprising drug in the skin-adhesive layer the adhesive comprising macromolecular compounds
- A61K9/7053—Transdermal patches of the drug-in-adhesive type, i.e. comprising drug in the skin-adhesive layer the adhesive comprising macromolecular compounds obtained by reactions only involving carbon to carbon unsaturated bonds, e.g. polyvinyl, polyisobutylene, polystyrene
- A61K9/7061—Polyacrylates
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/55—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having seven-membered rings, e.g. azelastine, pentylenetetrazole
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/70—Web, sheet or filament bases ; Films; Fibres of the matrix type containing drug
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P27/00—Drugs for disorders of the senses
- A61P27/02—Ophthalmic agents
- A61P27/12—Ophthalmic agents for cataracts
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A61P37/02—Immunomodulators
Landscapes
- Health & Medical Sciences (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Engineering & Computer Science (AREA)
- Animal Behavior & Ethology (AREA)
- Life Sciences & Earth Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Medicinal Chemistry (AREA)
- Chemical & Material Sciences (AREA)
- Epidemiology (AREA)
- Dermatology (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Organic Chemistry (AREA)
- Neurology (AREA)
- Biomedical Technology (AREA)
- Ophthalmology & Optometry (AREA)
- Neurosurgery (AREA)
- Immunology (AREA)
- Hospice & Palliative Care (AREA)
- Psychiatry (AREA)
- Medicinal Preparation (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Saccharide Compounds (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| DE4301783A DE4301783C1 (de) | 1993-01-23 | 1993-01-23 | Transdermales therapeutisches System mit Galanthamin als wirksamem Bestandteil |
| PCT/EP1994/000054 WO1994016707A1 (de) | 1993-01-23 | 1994-01-10 | Transdermales therapeutisches system mit galanthamin als wirksamen bestandteil |
Publications (3)
| Publication Number | Publication Date |
|---|---|
| NO952907L NO952907L (no) | 1995-07-21 |
| NO952907D0 true NO952907D0 (no) | 1995-07-21 |
| NO307497B1 NO307497B1 (no) | 2000-04-17 |
Family
ID=6478781
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| NO952907A NO307497B1 (no) | 1993-01-23 | 1995-07-21 | Transdermalt terapeutisk system for administrering av galanthamin bestanddel |
Country Status (26)
| Country | Link |
|---|---|
| US (1) | US5700480A (no) |
| EP (1) | EP0680325B1 (no) |
| JP (1) | JPH08505632A (no) |
| KR (1) | KR100300477B1 (no) |
| AT (1) | ATE216240T1 (no) |
| AU (1) | AU679032B2 (no) |
| CA (1) | CA2153572C (no) |
| CZ (1) | CZ287053B6 (no) |
| DE (2) | DE4301783C1 (no) |
| DK (1) | DK0680325T3 (no) |
| ES (1) | ES2176234T3 (no) |
| FI (1) | FI113744B (no) |
| HR (1) | HRP940028B1 (no) |
| HU (1) | HU221165B1 (no) |
| IL (1) | IL108235A (no) |
| MY (1) | MY109926A (no) |
| NO (1) | NO307497B1 (no) |
| NZ (1) | NZ259857A (no) |
| PH (1) | PH31473A (no) |
| PL (1) | PL175083B1 (no) |
| PT (1) | PT680325E (no) |
| SI (1) | SI9400024A (no) |
| SK (1) | SK281339B6 (no) |
| WO (1) | WO1994016707A1 (no) |
| YU (1) | YU48607B (no) |
| ZA (1) | ZA94414B (no) |
Families Citing this family (50)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| DE4429791C2 (de) * | 1994-08-23 | 1997-04-24 | Lohmann Therapie Syst Lts | Medizinischer Haftkleber auf Basis von Polyacrylaten und dessen Verwendung |
| DE19509663A1 (de) | 1995-03-17 | 1996-09-19 | Lohmann Therapie Syst Lts | Verfahren zur Isolierung von Galanthamin |
| AU732803B2 (en) * | 1996-01-17 | 2001-05-03 | National Starch And Chemical Investment Holding Corporation | Adhesives resistant to skin-penetration enhancers |
| AT402691B (de) * | 1996-01-26 | 1997-07-25 | Sanochemia Ltd | Verwendung von galanthamin zum herstellen von arzneimitteln zur behandlung von trisomie 21 oder verwandter trisomie-syndrome |
| US6512010B1 (en) | 1996-07-15 | 2003-01-28 | Alza Corporation | Formulations for the administration of fluoxetine |
| AU3601897A (en) * | 1996-07-15 | 1998-02-09 | Alza Corporation | Novel formulations for the administration of fluoxetine |
| DE19649534B4 (de) * | 1996-11-29 | 2004-05-06 | Lts Lohmann Therapie-Systeme Ag | Verpackung aus Verbundpackstoff zum Verpacken von wirkstoffhaltigen Pflastern |
| DE19653605C2 (de) * | 1996-12-20 | 2002-11-28 | Roehm Gmbh | Haft- und Bindemittel für dermale oder transdermale Therapiesysteme und dessen Verwendung zur Herstellung eines transdermalen Therapiesystems |
| US6203817B1 (en) | 1997-02-19 | 2001-03-20 | Alza Corporation | Reduction of skin reactions caused by transdermal drug delivery |
| US5968547A (en) | 1997-02-24 | 1999-10-19 | Euro-Celtique, S.A. | Method of providing sustained analgesia with buprenorphine |
| US6193993B1 (en) | 1998-03-03 | 2001-02-27 | Eisai Co., Ltd. | Suppository containing an antidementia medicament |
| OA11740A (en) * | 1998-12-24 | 2005-05-13 | Janssen Pharmaceutica Nv | Controlled release galantamine composition. |
| US6241998B1 (en) | 1999-02-02 | 2001-06-05 | Acutek International | Dermatological patch |
| DE19906977C1 (de) * | 1999-02-19 | 2000-06-15 | Lohmann Therapie Syst Lts | Desoxypeganin-TTS und seine Verwendung |
| WO2001026648A1 (en) * | 1999-10-13 | 2001-04-19 | Senju Pharmaceutical Co., Ltd. | Ophthalmic adhesive preparations for percutaneous absorption |
| MXPA02005667A (es) * | 1999-12-10 | 2004-09-10 | Bonnie Davis | Analogos de galantamina y licoramina como moduladores de los receptores nicotinicos. |
| WO2001090392A1 (en) * | 2000-05-26 | 2001-11-29 | Sumitomo Pharmaceuticals Company, Limited | Novel recombinant adenovirus vector with relieved side effects |
| FR2814368B1 (fr) * | 2000-09-26 | 2004-05-07 | Pf Medicament | Preparation pharmaceutique a base d'oxans |
| DE10141652B4 (de) * | 2001-08-24 | 2011-04-07 | Lts Lohmann Therapie-Systeme Ag | Transdermales therapeutisches System auf der Basis von Polyacrylat-Haftklebern ohne funktionelle Gruppen und seine Verwendung |
| DE10235556A1 (de) * | 2002-08-03 | 2004-02-19 | Hf Arzneimittelforschung Gmbh | Medikament und Verfahren zur Verringerung des Alkohol- und/oder Tabakkonsums |
| US20050143350A1 (en) * | 2003-11-19 | 2005-06-30 | Seed John C. | Combination drug therapy to treat obesity |
| US20050142193A1 (en) * | 2003-12-31 | 2005-06-30 | Lijuan Tang | Galantamine formulations |
| CA2551946A1 (en) * | 2003-12-31 | 2005-07-21 | Actavis Group Hf | Immediate, controlled and sustained release formulations of galantamine |
| AT500143A1 (de) * | 2004-04-22 | 2005-11-15 | Sanochemia Pharmazeutika Ag | Cholinesterase-inhibitoren in liposomen sowie deren herstellung und verwendung |
| DE602006016441D1 (de) * | 2005-05-13 | 2010-10-07 | Alza Corp | Mehrlagiges arzneimittelausbringsystem mit sperre gegen reservoirmaterialfluss |
| WO2007035941A2 (en) * | 2005-09-23 | 2007-03-29 | Alza Corporation | Transdermal galantamine delivery system |
| TWI389709B (zh) * | 2005-12-01 | 2013-03-21 | Novartis Ag | 經皮治療系統 |
| DE102008059054A1 (de) | 2008-11-26 | 2010-05-27 | Otto Bock Pur Life Science Gmbh | Polyurethanpflaster für die transdermale Applikation von Wirkstoffen und Verfahren zu dessen Herstellung |
| BR112013012156A2 (pt) | 2010-11-17 | 2017-12-05 | Hexal Ag | sistema terapêutico transdérmico e método de produção de um sistema terapêutico transdérmico |
| KR101317158B1 (ko) * | 2011-02-18 | 2013-10-15 | 조선대학교산학협력단 | 갈란타민 또는 그의 염을 함유하는 경피흡수제제 |
| ES2885523T3 (es) | 2011-11-23 | 2021-12-14 | Therapeuticsmd Inc | Formulaciones y terapias de reposición hormonal de combinación naturales |
| US9301920B2 (en) | 2012-06-18 | 2016-04-05 | Therapeuticsmd, Inc. | Natural combination hormone replacement formulations and therapies |
| US10806740B2 (en) | 2012-06-18 | 2020-10-20 | Therapeuticsmd, Inc. | Natural combination hormone replacement formulations and therapies |
| US20150196640A1 (en) | 2012-06-18 | 2015-07-16 | Therapeuticsmd, Inc. | Progesterone formulations having a desirable pk profile |
| US10806697B2 (en) | 2012-12-21 | 2020-10-20 | Therapeuticsmd, Inc. | Vaginal inserted estradiol pharmaceutical compositions and methods |
| US20130338122A1 (en) | 2012-06-18 | 2013-12-19 | Therapeuticsmd, Inc. | Transdermal hormone replacement therapies |
| US9180091B2 (en) | 2012-12-21 | 2015-11-10 | Therapeuticsmd, Inc. | Soluble estradiol capsule for vaginal insertion |
| US11246875B2 (en) | 2012-12-21 | 2022-02-15 | Therapeuticsmd, Inc. | Vaginal inserted estradiol pharmaceutical compositions and methods |
| US10471072B2 (en) | 2012-12-21 | 2019-11-12 | Therapeuticsmd, Inc. | Vaginal inserted estradiol pharmaceutical compositions and methods |
| US11266661B2 (en) | 2012-12-21 | 2022-03-08 | Therapeuticsmd, Inc. | Vaginal inserted estradiol pharmaceutical compositions and methods |
| US10568891B2 (en) | 2012-12-21 | 2020-02-25 | Therapeuticsmd, Inc. | Vaginal inserted estradiol pharmaceutical compositions and methods |
| US10537581B2 (en) | 2012-12-21 | 2020-01-21 | Therapeuticsmd, Inc. | Vaginal inserted estradiol pharmaceutical compositions and methods |
| MX2016014281A (es) | 2014-05-22 | 2017-02-22 | Therapeuticsmd Inc | Formulaciones y terapias de reemplazo de combinación de hormonas naturales. |
| JP6285820B2 (ja) * | 2014-08-07 | 2018-02-28 | 久光製薬株式会社 | ガランタミン含有経皮吸収製剤 |
| US10328087B2 (en) | 2015-07-23 | 2019-06-25 | Therapeuticsmd, Inc. | Formulations for solubilizing hormones |
| US10286077B2 (en) | 2016-04-01 | 2019-05-14 | Therapeuticsmd, Inc. | Steroid hormone compositions in medium chain oils |
| AU2017239645A1 (en) | 2016-04-01 | 2018-10-18 | Therapeuticsmd, Inc. | Steroid hormone pharmaceutical composition |
| US20180008612A1 (en) * | 2016-07-11 | 2018-01-11 | Taho Pharmaceuticals Ltd. | Transdermal delivery system containing galantamine or salts thereof |
| JP7515582B2 (ja) | 2019-11-06 | 2024-07-12 | スマーテック トピカル，インコーポレイテッド | シクロオキシゲナーゼ阻害剤の局所配合剤およびその使用 |
| US11633405B2 (en) | 2020-02-07 | 2023-04-25 | Therapeuticsmd, Inc. | Steroid hormone pharmaceutical formulations |
Family Cites Families (5)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| AU560710B2 (en) * | 1983-04-27 | 1987-04-16 | Lohmann Gmbh & Co. Kg. | Pharmaceutical product |
| US4663318A (en) * | 1986-01-15 | 1987-05-05 | Bonnie Davis | Method of treating Alzheimer's disease |
| DE3843239C1 (no) * | 1988-12-22 | 1990-02-22 | Lohmann Therapie Syst Lts | |
| DE4010079A1 (de) * | 1990-03-29 | 1991-10-02 | Lohmann Therapie Syst Lts | Pharmazeutische formulierung zur behandlung des alkoholismus |
| DE69229781T2 (de) * | 1991-05-14 | 2000-01-05 | Ernir Snorrason | Behandlung des ermüdungssyndroms mit cholinesteraseinhibitoren |
-
1993
- 1993-01-23 DE DE4301783A patent/DE4301783C1/de not_active Expired - Lifetime
- 1993-12-30 IL IL10823593A patent/IL108235A/en not_active IP Right Cessation
-
1994
- 1994-01-10 HU HU9501928A patent/HU221165B1/hu not_active IP Right Cessation
- 1994-01-10 EP EP94905024A patent/EP0680325B1/de not_active Expired - Lifetime
- 1994-01-10 CZ CZ19951842A patent/CZ287053B6/cs not_active IP Right Cessation
- 1994-01-10 AU AU58817/94A patent/AU679032B2/en not_active Ceased
- 1994-01-10 ES ES94905024T patent/ES2176234T3/es not_active Expired - Lifetime
- 1994-01-10 PL PL94309603A patent/PL175083B1/pl not_active IP Right Cessation
- 1994-01-10 PT PT94905024T patent/PT680325E/pt unknown
- 1994-01-10 US US08/495,609 patent/US5700480A/en not_active Expired - Lifetime
- 1994-01-10 DE DE59410103T patent/DE59410103D1/de not_active Expired - Lifetime
- 1994-01-10 AT AT94905024T patent/ATE216240T1/de active
- 1994-01-10 NZ NZ259857A patent/NZ259857A/en not_active IP Right Cessation
- 1994-01-10 DK DK94905024T patent/DK0680325T3/da active
- 1994-01-10 CA CA002153572A patent/CA2153572C/en not_active Expired - Fee Related
- 1994-01-10 JP JP6516614A patent/JPH08505632A/ja active Pending
- 1994-01-10 WO PCT/EP1994/000054 patent/WO1994016707A1/de not_active Ceased
- 1994-01-10 SK SK889-95A patent/SK281339B6/sk not_active IP Right Cessation
- 1994-01-10 KR KR1019950703008A patent/KR100300477B1/ko not_active Expired - Fee Related
- 1994-01-17 MY MYPI94000112A patent/MY109926A/en unknown
- 1994-01-19 PH PH47631A patent/PH31473A/en unknown
- 1994-01-20 ZA ZA94414A patent/ZA94414B/xx unknown
- 1994-01-20 HR HRP4301783.5A patent/HRP940028B1/xx not_active IP Right Cessation
- 1994-01-21 SI SI9400024A patent/SI9400024A/sl unknown
- 1994-01-21 YU YU2694A patent/YU48607B/sh unknown
-
1995
- 1995-07-21 NO NO952907A patent/NO307497B1/no not_active IP Right Cessation
- 1995-07-21 FI FI953533A patent/FI113744B/fi not_active IP Right Cessation
Also Published As
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| NO952907L (no) | Transdermalt terapeutisk system med galanthamin som virksom bestanddel | |
| BR0109893A (pt) | Preparação farmacêutica de lerisetron na forma de um sistema terapêutico transdêrmico, uso da preparação, uso da substância ativa lerisetron e método para administrar a substância ativa lerisetron a um paciente | |
| NO952908D0 (no) | Nitroglycerolholdig plaster, fremgangsmåte for fremstilling, samt anvendelse av plasteret | |
| LV10749A (lv) | Transdermala terapeitiska sistema fizostigmina uzliksanai uz adas un tas izgatavosanas panemiens |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| MM1K | Lapsed by not paying the annual fees |